Jeremy Schild

Jeremy Schild has a diverse work experience in business development, primarily in the pharmaceutical and clinical research industry. Jeremy is currently working at Cytel as the Executive Director of Business Development, where their role involves developing partnerships and assisting customers in the development of life-changing medicines. Prior to this, they held positions at GBA Group Pharma, Novella Clinical, TKL Research, Medpace, Kendle International, Kendle, and Index Pharmaceutical, where they gained extensive experience in various aspects of business development and sales. Overall, Jeremy's expertise lies in building relationships with key sites, advancing goals in bringing products to market, and recruiting and managing teams of professionals in the pharmaceutical industry.

Jeremy Schild attended Yateley School from 1983 to 1990, where they earned their A levels. Following this, they enrolled at Solent University from 1992 to 1994, obtaining an HND in Business & Finance.